As we get ready to go back to work, businesses are facing new challenges and realities that are complicated by uncertainties about the progression of COVID-19. We know that it’s not just a matter of returning to normal. Continued social distancing, stringent cleaning...
Featured posts
All posts
The new normal: How to ensure compliance during COVID-19
In recent weeks, the National Drug & Alcohol Screening Association (NDASA) has hosted a series of COVID-19 Townhall Discussions for its members in the drug and alcohol screening industry. The main takeaways from these meetings? Our members are passionate...
SAP Clearinghouse questions & answers
Since the launching of the new Federal Motor Carrier Safety Administration Drug and Alcohol Clearinghouse in January 2020 many questions have arisen about Clearinghouse processes and procedures. Everyone is committed to making the database work well for all...
NDASA guidance and U.S. DOT response to COVID-19
In light of recent reports that the Federal Motor Carriers Safety Administration (FMCSA) and other transportation modes are considering suspending random drug testing requirements during the COVID-19 health crisis, the National Drug and Alcohol Screening...